November 11, 2013

Boehringer Ingelheim's interferon-free hepatitis C treatment portfolio strengthened by promising Phase II data

Video: HCV Video Series: Individualised HCV

Boehringer Ingelheim (Canada) Ltd.

Canada NewsWire

Source

Also See: Boehringer Ingelheim's interferon-free hepatitis C treatment portfolio strengthened by promising Phase II data (Press release November 01, 2013)

No comments:

Post a Comment